Primary androgen deprivation (PAD) followed by active surveillance for newly diagnosed prostate cancer (PC)

被引：0
|
作者：
Scholz, Mark Creamer
Groom, Meg
Kaddis, Andrew
Lam, Richard Y.
Jennrich, Robert
机构：
[1] Prostate Oncol Specialists, Marina Del Rey, CA USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.244
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
244
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC REPLY
    不详
    JOURNAL OF UROLOGY, 2019, 201 (05): : 936 - 936
  • [22] The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer
    Wong, Yu-Ning
    Freedland, Stephen J.
    Egleston, Brian
    Vapiwala, Neha
    Uzzo, Robert
    Armstrong, Katrina
    EUROPEAN UROLOGY, 2009, 56 (04) : 609 - 616
  • [23] Can androgen deprivation be considered a primary treatment for prostate cancer?
    Kirk, D
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (03): : 126 - 127
  • [24] Can androgen deprivation be considered a primary treatment for prostate cancer?
    David Kirk
    Nature Clinical Practice Urology, 2006, 3 : 126 - 127
  • [25] Primary androgen deprivation for prostate cancer: perspective from CaPSURE
    Cooperberg, Matthew R.
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (08) : 704 - 704
  • [26] The Cardiotoxic Effect of Androgen Deprivation Therapy on the Genome of Men Diagnosed with Prostate Cancer
    Mullen, McKay
    Guha, Avirup
    Weintraub, Neal
    Nain, Priyanshu
    Simon, Abigayle
    Elsayed, Omar
    Kunhiraman, Harikrishnan Hyma
    Harris, Ryan
    CIRCULATION, 2024, 150
  • [27] Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial
    Dai, Bo
    Zhang, Sheng
    Wan, Fang-Ning
    Wang, Hong-Kai
    Zhang, Jun -Yu
    Wang, Qi-Feng
    Kong, Yun-Yi
    Ma, Xue-Jun
    Mo, Miao
    Zhu, Yao
    Qin, Xiao-Jian
    Lin, Guo-Wen
    Ye, Ding -Wei
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 519 - 525
  • [28] Influence of one-year androgen deprivation therapy on lipid and glucose metabolism in patients with newly diagnosed prostate cancer.
    Mitsuzuka, Koji
    Kyan, Atsushi
    Orikasa, Kazuhiko
    Fukushi, Yasuo
    Aoki, Hiroshi
    Narita, Shintaro
    Koie, Takuya
    Miyazato, Minoru
    Kakoi, Narihiko
    Arai, Yoichi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [29] Primary Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer in Asia: Unique or Not?
    Shiota, Masaki
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 523 - 524
  • [30] Cessation of Primary Androgen Deprivation Therapy for Men With Localized Prostate Cancer
    Fujimoto, Naohiro
    Kubo, Tatsuhiko
    Tomisaki, Ikko
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : 359 - 363
12345